Immunic reported 197K in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
BioMarin Pharmaceutical USD 14.96M 12.18M Mar/2026
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 215M 111M Dec/2025
Enanta Pharmaceuticals USD 1.96M 620K Dec/2024
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 197K 222K Dec/2025
Insmed USD 20.6M 217K Dec/2025
Omeros USD 4.05M 5.16M Sep/2024
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Ultragenyx Pharmaceutical USD 21M 2M Mar/2026
United Therapeutics USD 3.1M 100K Dec/2025
Xoma USD 3.4M 150K Jun/2024